Minimum between doses: 72 hours Flexibility window: Must maintain 3-day minimum gap Missed dose window: 4 days One day early risk level: Low (as long as 72+ hours maintained) Compounded tirzepatide follows the same rules
Thyroid function was monitored, and no clinically meaningful changes in thyroid parameters were attributed to semaglutide in participants without pre-existing thyroid conditions (Wilding et al., 2021, NEJM )
Change in eGFR (cystatin C) relative to baseline over time by eGFR subgroup
The use of GLP-1 analogues during pregnancy is generally not recommended due to limited safety data
Improved quality of life: Obesity is associated with a number of negative health outcomes, including increased risk of heart disease, diabetes, and certain cancers
Your doctor will give you a plan to start with a small dose and slowly increase it